NDC 69452-341

Naratriptan

Naratriptan

Naratriptan is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bionpharma Inc.. The primary component is Naratriptan Hydrochloride.

Product ID69452-341_81b216d9-f05f-473c-97f6-e3b7ffc63be6
NDC69452-341
Product TypeHuman Prescription Drug
Proprietary NameNaratriptan
Generic NameNaratriptan
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2022-04-11
Marketing CategoryANDA /
Application NumberANDA091441
Labeler NameBionpharma Inc.
Substance NameNARATRIPTAN HYDROCHLORIDE
Active Ingredient Strength3 mg/1
Pharm ClassesSerotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 69452-341-72

1 BLISTER PACK in 1 CARTON (69452-341-72) > 9 TABLET, FILM COATED in 1 BLISTER PACK (69452-341-60)
Marketing Start Date2022-04-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Naratriptan" or generic name "Naratriptan"

NDCBrand NameGeneric Name
0054-0278NaratriptanNaratriptan
0054-0279NaratriptanNaratriptan
0781-5527NaratriptanNaratriptan
23155-054naratriptannaratriptan
23155-055naratriptannaratriptan
42043-130NaratriptanNaratriptan
42043-131NaratriptanNaratriptan
50090-6162NaratriptanNaratriptan
69452-340NaratriptanNaratriptan
69452-341NaratriptanNaratriptan

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.